Christina Lampe-Onnerud - 04 Jan 2024 Form 4 Insider Report for Livent Corp.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Jan 2024, 16:00:49 UTC
Prior SEC filing
06 Sep 2023
Next SEC filing
11 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sara Ponessa, as attorney-in-fact

Key filing fact

Christina Lampe-Onnerud filed Form 4 for Livent Corp. on 08 Jan 2024.

Key facts

  • This page summarizes Christina Lampe-Onnerud's Form 4 filing for Livent Corp..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Jan 2024, 16:00.

Change

  • Previous filing in this sequence was filed on 06 Sep 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LTHM transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-32,307
Change %
-100%
Price
Shares after
0
Date
04 Jan 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Christina Lampe-Onnerud is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .